10 results  1 of 1 

1 Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse
Xinyu Wan, Xiaomin Yang, Fan Yang, Tianyi Wang, Lixia Ding, Lili Song, Yan Miao, Xiang Wang, Yani Ma, Chengjuan Luo, Jingyan Tang, Longjun Gu, Jing Chen, Yanjing Tang, Jun Lu, Benshang Li
Cancer Res Treat.2022;54(3):917-925.   Published online 2021 September 17     DOI: http://dx.doi.org/10.4143/crt.2021.399
      
2 Novel combination immunochemotherapy beyond CD20 for B-cell lymphomas
Jun Ho Yi
Blood Res.2021;56(S1):1-4.   Published online 2021 April 30     DOI: http://dx.doi.org/10.5045/br.2021.2020320
      
3 Abnormal B Lymphocyte Activation and Function in Systemic Sclerosis
Ayumi Yoshizaki, Shinichi Sato
Ann Dermatol.2015;27(1):1-9.   Published online 2015 February 3     DOI: http://dx.doi.org/10.5021/ad.2015.27.1.1
      
4 Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells
Tae-Dong Jeong, Chan-Jeoung Park, Hyoeun Shim, Seongsoo Jang, Hyun-Sook Chi, Dok Hyun Yoon, Dae-Young Kim, Jung-Hee Lee, Je-Hwan Lee, Cheolwon Suh, Kyoo Hyung Lee
Korean J Hematol.2012;47(4):260-266.   Published online 2012 December 24     DOI: http://dx.doi.org/10.5045/kjh.2012.47.4.260
      
5 IL-10 is Predominantly Produced by CD19(low)CD5(+) Regulatory B Cell Subpopulation: Characterisation of CD19 (high) and CD19(low) Subpopulations of CD5(+) B cells
Jae Ho Lee, Joonyong Noh, Geunwoong Noh, Wahn Soo Choi, Sang Sun Lee
Yonsei Med J.2011;52(5):851-855.   Published online 2011 July 18     DOI: http://dx.doi.org/10.3349/ymj.2011.52.5.851
      
6 Presence of Foxp3-expressing CD19(+)CD5(+) B Cells in Human Peripheral Blood Mononuclear Cells: Human CD19(+)CD5(+)Foxp3(+) Regulatory B Cell (Breg)
Joonyong Noh, Wahn Soo Choi, Geunwoong Noh, Jae Ho Lee
Immune Netw.2010;10(6):247-249.   Published online 2010 December 31     DOI: http://dx.doi.org/10.4110/in.2010.10.6.247
      
7 Distribution of Antigenic Aberration in the Bone Marrow of Acute Leukemia in Complete Remission
Soyoung Shin, Jimin Kahng, Myungshin Kim, Jihyang Lim, Younggoo Kim, Kyungja Han
Korean J Lab Med.2008;28(1):1-7.   Published online 2008 February 14     DOI: http://dx.doi.org/10.3343/kjlm.2008.28.1.1
   
8 Proportions of Cells Expressing CD38-/CD34+, CD38+/CD34+, CD19+/CD34+, or CD13,33+/CD34+ in the Regenerating Bone Marrows During Complete Remission of Acute Leukemia or After Bone Marrow Transplantation
Jimin Kahng, So-Young Shin, Kyungja Han
Korean J Lab Med.2007;27(6):406-413.   Published online 2007 February 14     DOI: http://dx.doi.org/10.3343/kjlm.2007.27.6.406
   
9 A Case of CD45-, CD19-Precursor B Cell Acute Lymphoblastic Leukemia with an Atypical Morphology
Heewon Moon, Jungwon Huh, Min-Sun Cho, Hyunsook Chi, Wha Soon Chung
Korean J Lab Med.2007;27(4):253-256.   Published online 2007 February 10     DOI: http://dx.doi.org/10.3343/kjlm.2007.27.4.253
   
10 A Case of Acute Lymphoblastic Leukemia with Maturation
Jeong-Hun Kim, Woo-In Lee, Su-Yon Park, Hwi-Joong Yoon, So-Young Kang, Jin-Tae Suh
Korean J Hematol.2006;41(1):46-50.   Published online 2006 March 19     DOI: http://dx.doi.org/10.5045/kjh.2006.41.1.46
   

 1 of 1